Leverage Shares 2X Long GEMI Daily ETF (GEMG)

From a quantitative risk perspective, GEMG is exhibiting textbook symptoms of an impaired leveraged vehicle. With an AUM hovering around $520K to $681K and average daily volumes under $42,000, the fund is functionally untradeable for any meaningful institutional or retail size. The 1-year beta of 1.11 completely fails to deliver the promised 2x daily mandate, while Morningstar flags both risk and return as 'Low' against the peer group simply because the fund barely trades. Furthermore, the 96.8% drop from its November 2025 all-time high of $17.73 down to fractional dollar levels highlights catastrophic path-dependency and compounding destruction.

On our desk, market sentiment for GEMG is practically radioactive. The product fits no standard retail use-case: bid-ask spreads can widen up to 99.87%, utterly crushing any short-term trading thesis. Even though it registers intermittent oversold RSI signals and minor bounces off its lows, the sheer structural drag of swap-heavy weightings—such as the massive Marex swap exposure—combined with microscopic liquidity means investors face extreme unpriced slippage and impending delisting or liquidation risk.

When evaluating derivative-heavy structures like GEMG for tactical allocation, our protocol mandates strict avoidance when assets under management drop below a $500M safety floor. GEMG’s micro-cap asset base, 0% portfolio turnover of underlying physical holdings, and reliance on complex swap counterparties like Marex and Cantor introduce severe counterparty and tracking errors. Anyone modeling entry points must account for the reality that daily rebalancing volatility can erase principal far faster than the underlying equity's directional moves.